HI
Hudock Inc’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-4,360
| Closed | -$128K | – | 361 |
|
2022
Q3 | $128K | Sell |
4,360
-576
| -12% | -$16.9K | 0.04% | 172 |
|
2022
Q2 | $214K | Buy |
4,936
+53
| +1% | +$2.3K | 0.07% | 134 |
|
2022
Q1 | $212K | Buy |
4,883
+25
| +0.5% | +$1.09K | 0.06% | 147 |
|
2021
Q4 | $214K | Buy |
4,858
+29
| +0.6% | +$1.28K | 0.06% | 155 |
|
2021
Q3 | $184K | Buy |
4,829
+28
| +0.6% | +$1.07K | 0.06% | 159 |
|
2021
Q2 | $191K | Sell |
4,801
-976
| -17% | -$38.8K | 0.06% | 156 |
|
2021
Q1 | $206K | Buy |
5,777
+42
| +0.7% | +$1.5K | 0.06% | 138 |
|
2020
Q4 | $211K | Buy |
5,735
+1,028
| +22% | +$37.8K | 0.07% | 135 |
|
2020
Q3 | $177K | Buy |
4,707
+23
| +0.5% | +$865 | 0.07% | 134 |
|
2020
Q2 | $191K | Buy |
4,684
+30
| +0.6% | +$1.22K | 0.07% | 117 |
|
2020
Q1 | $176K | Sell |
4,654
-79
| -2% | -$2.99K | 0.07% | 101 |
|
2019
Q4 | $222K | Buy |
4,733
+22
| +0.5% | +$1.03K | 0.07% | 106 |
|
2019
Q3 | $201K | Buy |
4,711
+23
| +0.5% | +$981 | 0.07% | 106 |
|
2019
Q2 | $187K | Buy |
4,688
+20
| +0.4% | +$798 | 0.07% | 111 |
|
2019
Q1 | $195K | Buy |
4,668
+600
| +15% | +$25.1K | 0.07% | 112 |
|
2018
Q4 | $155K | Buy |
4,068
+2,444
| +150% | +$93.1K | 0.06% | 114 |
|
2018
Q3 | $65K | Buy |
1,624
+107
| +7% | +$4.28K | 0.03% | 212 |
|
2018
Q2 | $61K | Sell |
1,517
-295
| -16% | -$11.9K | 0.02% | 210 |
|
2018
Q1 | $70K | Buy |
1,812
+22
| +1% | +$850 | 0.03% | 200 |
|
2017
Q4 | $63K | Buy |
1,790
+122
| +7% | +$4.29K | 0.03% | 212 |
|
2017
Q3 | $67K | Buy |
1,668
+177
| +12% | +$7.11K | 0.03% | 200 |
|
2017
Q2 | $64K | Buy |
1,491
+13
| +0.9% | +$558 | 0.03% | 196 |
|
2017
Q1 | $62K | Buy |
1,478
+8
| +0.5% | +$336 | 0.03% | 194 |
|
2016
Q4 | $56K | Buy |
1,470
+307
| +26% | +$11.7K | 0.03% | 203 |
|
2016
Q3 | $50K | Buy |
1,163
+8
| +0.7% | +$344 | 0.03% | 221 |
|
2016
Q2 | $50K | Buy |
1,155
+19
| +2% | +$823 | 0.03% | 226 |
|
2016
Q1 | $46K | Buy |
1,136
+8
| +0.7% | +$324 | 0.03% | 237 |
|
2015
Q4 | $45K | Buy |
1,128
+10
| +0.9% | +$399 | 0.02% | 225 |
|
2015
Q3 | $43K | Buy |
1,118
+8
| +0.7% | +$308 | 0.02% | 231 |
|
2015
Q2 | $46K | Buy |
1,110
+9
| +0.8% | +$373 | 0.02% | 218 |
|
2015
Q1 | $51K | Buy |
1,101
+9
| +0.8% | +$417 | 0.02% | 207 |
|
2014
Q4 | $47K | Buy |
1,092
+8
| +0.7% | +$344 | 0.02% | 215 |
|
2014
Q3 | $50K | Buy |
1,084
+187
| +21% | +$8.63K | 0.03% | 206 |
|
2014
Q2 | $48K | Buy |
897
+8
| +0.9% | +$428 | 0.05% | 211 |
|
2014
Q1 | $48K | Buy |
889
+7
| +0.8% | +$378 | 0.04% | 201 |
|
2013
Q4 | $47K | Buy |
882
+6
| +0.7% | +$320 | 0.04% | 196 |
|
2013
Q3 | $44K | Buy |
876
+6
| +0.7% | +$301 | 0.04% | 170 |
|
2013
Q2 | $43K | Buy |
+870
| New | +$43K | 0.06% | 175 |
|